ESLA
Estrella Immunopharma Inc.
0.468$
-1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -15.7% | +153.8% | +458.5% | +150.0% | +0.1% | +0.6% | -1.8% | -81.2% | -84.4% | -66.9% | +14,000.0% | -19.8% | -98.8% | +4,230.2% | +230.5% | -10.9% | -99.4% | +5,409.9% | 0.0% | – | |
| – | – | -87.0% | -43.7% | +76.8% | +768.8% | -47.0% | -20.7% | +32.3% | +790.7% | -31.9% | -53.0% | -4.5% | +29.8% | +84.8% | -31.8% | +27.3% | -26.6% | -9.4% | +51.7% | -23.3% | – | |
| – | – | -2.1% | +58.9% | +538.3% | +168.6% | -4.5% | -0.6% | -0.4% | -31.5% | -45.4% | -54.0% | +741.1% | -14.5% | -68.9% | +100.4% | +163.5% | -13.4% | -87.2% | +273.8% | -9.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -75.9% | +8.3% | -297.3% | – | – | -95.9% | +0.0% | -96.1% | -79.4% | +6,438.5% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.